- Home
- GENI vs LNTH Comparison
GENI vs LNTH Comparison
Compare GENI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENI
- LNTH
- Stock Information
- Founded
- GENI 2016
- LNTH 1956
- Country
- GENI United Kingdom
- LNTH United States
- Employees
- GENI N/A
- LNTH N/A
- Industry
- GENI Services-Misc. Amusement & Recreation
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GENI Consumer Discretionary
- LNTH Health Care
- Exchange
- GENI Nasdaq
- LNTH Nasdaq
- Market Cap
- GENI 3.0B
- LNTH 3.6B
- IPO Year
- GENI N/A
- LNTH 2015
- Fundamental
- Price
- GENI $12.48
- LNTH $52.78
- Analyst Decision
- GENI Strong Buy
- LNTH Strong Buy
- Analyst Count
- GENI 16
- LNTH 5
- Target Price
- GENI $13.75
- LNTH $91.60
- AVG Volume (30 Days)
- GENI 4.9M
- LNTH 1.6M
- Earning Date
- GENI 08-06-2025
- LNTH 11-05-2025
- Dividend Yield
- GENI N/A
- LNTH N/A
- EPS Growth
- GENI N/A
- LNTH N/A
- EPS
- GENI N/A
- LNTH 3.77
- Revenue
- GENI $558,439,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- GENI $27.93
- LNTH N/A
- Revenue Next Year
- GENI $16.92
- LNTH $3.24
- P/E Ratio
- GENI N/A
- LNTH $14.58
- Revenue Growth
- GENI 25.76
- LNTH 5.75
- 52 Week Low
- GENI $6.72
- LNTH $47.25
- 52 Week High
- GENI $13.73
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- GENI 49.54
- LNTH 38.29
- Support Level
- GENI $12.31
- LNTH $51.94
- Resistance Level
- GENI $13.73
- LNTH $55.24
- Average True Range (ATR)
- GENI 0.41
- LNTH 1.96
- MACD
- GENI -0.13
- LNTH 0.46
- Stochastic Oscillator
- GENI 14.40
- LNTH 10.57
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.